- Home
- About Sonexa
- Research & Development
- Patient Resources
- News & Events
- Contact
Sonexa is actively conducting two Phase II Proof-of-Concept trials in Alzheimer’s disease.
For information on clinical trials being conducted with ST101, including the location of clinical trial centers, please see the following ClinicalTrials.gov links:
Preliminary Efficacy and Safety Study of ST101 Plus Aricept in Alzheimer's Disease
Preliminary Efficacy and Safety Study of ST101 in Alzheimer's Disease
For additional information on Alzheimer's disease, please contact: